Advanced glycation end products: role in pathology of diabetic cardiomyopathy

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes

(2012) Bruce A. Perkins et al.   PLoS One

Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling

(2012) Allyson L. Kranstuber et al.   Frontiers in Physiology

Activation of the ROCK1 Branch of the Transforming Growth Factor-β Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice

(2010) De-xiu Bu et al.   CIRCULATION RESEARCH

Reductive Metabolism of AGE Precursors: A Metabolic Route for Preventing AGE Accumulation in Cardiovascular Tissue

(2009) S. P. Baba et al.   DIABETES

Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice

(2009) Jan M. Nielsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes

(2009) Deepa Joshi et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Advanced Glycation End Products in the Development of Ischemic and Dilated Cardiomyopathy in Patients With Diabetes Mellitus Type 2

(2009) J. Nożyński et al.   TRANSPLANTATION PROCEEDINGS

RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium

(2008) L. G. Bucciarelli et al.   DIABETES

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

(2008) Heng Ma et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The Role of Advanced Glycation End Products in Progression and Complications of Diabetes

(2008) Su-Yen Goh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats

(2007) Manuela Aragno et al.   ENDOCRINOLOGY